Pharmacosmos
Pharmacosmos A/S, a leading player in the pharmaceutical industry, is headquartered in Denmark (DK) and operates extensively across Europe and beyond. Founded in 1983, the company has established itself as a specialist in iron deficiency treatment, focusing on innovative therapies that enhance patient care. Pharmacosmos is renowned for its core products, including intravenous iron formulations, which are distinguished by their efficacy and safety profiles. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted partner in the healthcare sector. With a strong market presence and a dedication to improving patient outcomes, Pharmacosmos continues to make notable contributions to the treatment of iron deficiency and related conditions.
DitchCarbon Score
How does Pharmacosmos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmacosmos's score of 3 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmacosmos's reported carbon emissions
Pharmacosmos, headquartered in Denmark (DK), currently does not have publicly available carbon emissions data or specific reduction targets outlined in their climate commitments. Without concrete figures or defined initiatives, it is challenging to assess their current carbon footprint or climate action strategies. However, the company may still be engaged in broader industry efforts to address climate change, aligning with global sustainability trends. As the landscape of corporate climate commitments evolves, Pharmacosmos may develop and disclose future targets and initiatives aimed at reducing their environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmacosmos is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
